Published in Am J Surg Pathol on March 01, 2003
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol (2014) 3.21
Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol (2012) 1.59
The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol (2007) 1.44
Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res (2009) 1.39
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer (2009) 1.32
Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol (2003) 1.20
Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology (2009) 1.17
A male presenting with a primary mucinous bladder carcinoma: a case report. Cases J (2010) 1.17
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. World J Gastroenterol (2015) 1.14
Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol (2004) 1.13
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol (2012) 1.10
Pathophysiology and biology of peritoneal carcinomatosis. World J Gastrointest Oncol (2010) 1.07
Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol (2012) 1.06
Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol (2008) 1.03
CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg (2011) 1.01
Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch (2007) 1.00
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol (2012) 0.99
Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2'-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells. Exp Ther Med (2013) 0.96
Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset. Int J Clin Oncol (2013) 0.96
Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Am J Surg Pathol (2010) 0.94
Laparoscopic low anterior resection for hematogenous rectal metastasis from gastric adenocarcinoma: a case report. World J Surg Oncol (2011) 0.93
Metachronous Colon Metastases from Gastric Adenocarcinoma: A Case Report. Case Rep Oncol (2009) 0.93
Peritoneal mucinous cystadenocarcinoma of probable urachal origin: a challenging diagnosis. J Clin Pathol (2006) 0.93
High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei. Virchows Arch (2005) 0.92
Induction of cancer stem cell properties in colon cancer cells by defined factors. PLoS One (2014) 0.91
Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol (2013) 0.91
CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch (2003) 0.90
Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus. World J Gastroenterol (2013) 0.89
Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties. Cell Transplant (2010) 0.89
Molecular mechanisms of Barrett's esophagus. Dig Dis Sci (2011) 0.89
Metastasis to the breast from colonic adenocarcinoma. J Korean Surg Soc (2011) 0.89
New insights into the development and differentiation of the human anorectal epithelia. Are there clinical consequences? Int J Colorectal Dis (2010) 0.88
CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Arch (2004) 0.88
Mitochondrion-rich differentiated adenocarcinomas of the stomach: clinicopathological, immunohistochemical and electron microscopy study of nine cases. Virchows Arch (2010) 0.86
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. Hum Pathol (2012) 0.85
Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. World J Gastroenterol (2005) 0.85
Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2. Mol Cancer (2009) 0.85
The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray. J Korean Med Sci (2005) 0.85
Immunohistochemical profile for unknown primary adenocarcinoma. PLoS One (2012) 0.84
Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J (2010) 0.84
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case. Surg Today (2011) 0.84
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer. Front Oncol (2013) 0.84
Colonic carcinoma with a pancreatic acinar cell differentiation. A case report. Virchows Arch (2009) 0.83
Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder. Virchows Arch (2008) 0.83
CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch (2004) 0.82
Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as 'giant' ovarian tumors in an individual with probable Lynch syndrome: a case report. J Med Case Rep (2013) 0.82
My approach to intraductal lesions of the prostate gland. J Clin Pathol (2007) 0.82
Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg (2016) 0.82
Neuropathology of brain metastases. Surg Neurol Int (2013) 0.82
Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas. Hum Pathol (2009) 0.82
CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol (2004) 0.81
Primary colonic signet ring cell carcinoma presenting carcinocythemia: an autopsy case. Case Rep Gastroenterol (2008) 0.80
Relationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus. World J Gastroenterol (2013) 0.80
RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin. Neoplasia (2014) 0.80
HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch (2014) 0.80
Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries. J Clin Pathol (2006) 0.80
The role of Reg IV in colorectal cancer, as a potential therapeutic target. Contemp Oncol (Pozn) (2015) 0.79
Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. PLoS One (2014) 0.79
Metastasis of a cecal adenocarcinoma to the prostate five years after a right hemicolectomy: a case report. J Med Case Rep (2011) 0.79
Primary yolk sac tumor of the omentum: a case report and literature review. Case Rep Oncol (2012) 0.79
Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases. Mod Pathol (2016) 0.79
Colon cancer metastasis to the thyroid gland: report of a case with unique molecular profile. Clin Case Rep (2016) 0.79
Metastatic signet ring cell carcinoma of the bilateral breasts and ovaries from gastrointestinal tract in a young breastfeeding female - a case report. J Cancer (2011) 0.78
Clinical utility of image-guided peritoneal and omental biopsy. Nat Rev Clin Oncol (2010) 0.78
Porcine milk-derived exosomes promote proliferation of intestinal epithelial cells. Sci Rep (2016) 0.78
CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia. World J Gastroenterol (2015) 0.78
Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature. Int J Clin Exp Pathol (2015) 0.78
Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma. World J Gastrointest Surg (2010) 0.78
Characterization of azoxymethane-induced colon tumor metastasis to lung in a mouse model relevant to human sporadic colorectal cancer and evaluation of grape seed extract efficacy. Exp Toxicol Pathol (2014) 0.77
A Case of Gingival Metastasis from Rectal Cancer in Which Immunohistochemistry and PET-CT Were Useful for the Diagnostic Procedure. Case Rep Oncol (2014) 0.77
SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors. Int J Clin Exp Pathol (2015) 0.76
[The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas]. Pathologe (2006) 0.76
Loss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survival. ISRN Gastroenterol (2013) 0.76
Clinicopathological study of 9 cases of prostate cancer involving the rectal wall. Diagn Pathol (2017) 0.75
Urethral metastasis from a sigmoid colon carcinoma: a quite rare case report and review of the literature. BMC Surg (2014) 0.75
Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report. World J Surg Oncol (2016) 0.75
Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports. Ann Coloproctol (2016) 0.75
Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory. Acta Histochem Cytochem (2015) 0.75
Clear cell adenocarcinoma of the colon: a case report and review of the literature. Case Rep Oncol Med (2014) 0.75
Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins. Mod Pathol (2013) 0.75
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma. Cancer Med (2016) 0.75
Challenging diagnosis of a jejunal adenocarcinoma with ovarian metastasis: report of an unusual case. BMJ Case Rep (2013) 0.75
Colorectal cancer: Is the new era of colorectal cancer classification finally here? Nat Rev Gastroenterol Hepatol (2013) 0.75
Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors. Virchows Arch (2005) 0.75
A case of gastric adenocarcinoma in a Shih Tzu dog: successful treatment of early gastric cancer. J Vet Med Sci (2014) 0.75
Engineering a vascularised 3D in vitro model of cancer progression. Sci Rep (2017) 0.75
Overexpression of caudal-related homeobox transcription factor 2 inhibits the growth of transplanted colorectal tumors in nude mice. Mol Med Rep (2015) 0.75
Alterations of gastric homeoprotein expression in Helicobacter pylori infection, incisural antralisation, and intestinal metaplasia. Dig Dis Sci (2008) 0.75
Metastases of transverse colon cancer to bilateral ovaries (Krukenberg tumor) and the left breast: A case report. Oncol Lett (2017) 0.75
CDX2 immunostaining in primary and metastatic germ cell tumours of the testis. J Int Med Res (2016) 0.75
Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma. Oncotarget (2017) 0.75
Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes. Virchows Arch (2017) 0.75
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res (2004) 16.51
HER-2 testing in breast cancer using parallel tissue-based methods. JAMA (2004) 4.60
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol (2006) 3.42
Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol (2013) 3.04
An international Ki67 reproducibility study. J Natl Cancer Inst (2013) 2.46
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol (2008) 2.38
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol (2010) 2.28
Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol (2007) 2.24
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry. Appl Immunohistochem Mol Morphol (2009) 2.22
Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol (2011) 1.99
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2009) 1.85
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat (2007) 1.75
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res (2008) 1.73
Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol (2010) 1.65
Nuclear beta-catenin in mesenchymal tumors. Mod Pathol (2005) 1.60
Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma (2010) 1.50
A new morphological variant of uterine PEComas with sex-cord-like pattern and WT1 expression: more doubts about the existence of uterine PEComas. Ann Diagn Pathol (2009) 1.49
Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol (2006) 1.44
Unmasking the mysteries of antigen or epitope retrieval and formalin fixation. Am J Clin Pathol (2004) 1.39
Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol (2006) 1.36
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol (2006) 1.34
Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem (2003) 1.31
Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol (2010) 1.22
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol (2012) 1.21
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol (2006) 1.20
Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med (2007) 1.19
Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo) (2011) 1.17
Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol (2003) 1.16
Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol (2011) 1.16
Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol (2010) 1.14
Pharmacologically regulated in vivo selection in a large animal. Blood (2002) 1.12
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe. Diagn Mol Pathol (2005) 1.09
Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol (2009) 1.09
Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment. Brachytherapy (2005) 1.08
Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil. Int J Cancer (2004) 1.06
Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol (2008) 1.05
Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy. J Clin Oncol (2011) 1.05
B-cell and T-cell lymphomas of the breast: clinical--pathological features of 53 cases. Int J Surg Pathol (2008) 1.03
Emperipolesis in a case of B-cell lymphoma: a rare phenomenon outside of Rosai-Dorfman disease. Ann Diagn Pathol (2003) 1.03
p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol (2007) 1.02
Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol (2006) 1.01
DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol (2010) 1.01
Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance. Am J Surg Pathol (2007) 1.00
Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol (2004) 0.99
Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology. Arch Pathol Lab Med (2011) 0.99
Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J Otorhinolaryngol Relat Spec (2008) 0.98
Imatinib treatment for gastrointestinal stromal tumour (GIST). J Cell Mol Med (2009) 0.97
Primary cutaneous blastoid mantle cell lymphoma-case report. Am J Dermatopathol (2009) 0.97
Biomarker panel diagnosis of thyroid cancer: a critical review. Expert Rev Anticancer Ther (2008) 0.97
Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients. Clinics (Sao Paulo) (2010) 0.97
Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol (2009) 0.96
Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol (2009) 0.96
BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol (2015) 0.95
Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol (2006) 0.94
Accuracy and precision in HER2/neu testing in breast cancer: are we there yet? Hum Pathol (2004) 0.94
The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases. Mod Pathol (2012) 0.93
MUM1/IRF4: A Review. Appl Immunohistochem Mol Morphol (2010) 0.93
Postsplenectomy sclerosing extramedullary hematopoietic tumor with unexpected good clinical evolution: morphologic, immunohistochemical, and molecular analysis of one case and review of the literature. Appl Immunohistochem Mol Morphol (2010) 0.93
Low-grade endometrial stromal sarcoma presenting as vaginal nodule. Ann Diagn Pathol (2004) 0.93
IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am J Surg Pathol (2013) 0.93
BCL6, MUM1, and CD10 expression in mantle cell lymphoma. Appl Immunohistochem Mol Morphol (2010) 0.92
Immunohistochemical markers of melanocytic tumors. Int J Surg Pathol (2003) 0.91
Plasma cell myeloma presenting with diffuse pleural involvement: a hitherto unreported pattern of a new mesothelioma mimicker. Ann Diagn Pathol (2010) 0.91
Expression profiles of MYC protein and MYC gene rearrangement in lymphomas. Am J Surg Pathol (2015) 0.91
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. Blood (2012) 0.90
Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma. Diagn Pathol (2006) 0.90
Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. Hum Pathol (2009) 0.89
EGFR and gastrointestinal stromal tumor: an immunohistochemical and FISH study of 82 cases. Mod Pathol (2007) 0.89
Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Am J Clin Pathol (2008) 0.88
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. Am J Surg Pathol (2016) 0.87
Peliosis hepatis associated with lymphoplasmacytic lymphoma: an autopsy case report. Arch Pathol Lab Med (2004) 0.86
Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population. Clinics (Sao Paulo) (2012) 0.86
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol (2013) 0.86
Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol (2006) 0.85
Myxopapillary ependymoma of the posterior mediastinum. Ann Diagn Pathol (2006) 0.85
Viral studies in burkitt lymphoma: association with Epstein-Barr virus but not HHV-8. Am J Clin Pathol (2008) 0.84
Hodgkin disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein-Barr virus infection. Am J Clin Pathol (2002) 0.83
Signet ring cell angiosarcoma: a hitherto unreported pitfall in the diagnosis of epithelioid cutaneous malignancies. Am J Dermatopathol (2013) 0.83
Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol (2009) 0.82
Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Int J Gynecol Pathol (2007) 0.82
Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature. Int J Gynecol Pathol (2005) 0.82
Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol (2009) 0.82
Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study. World J Surg Oncol (2010) 0.82
Subcutaneous (deep) granuloma annulare in children: a possible mimicker of epithelioid sarcoma. Fetal Pediatr Pathol (2007) 0.82
Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome. Am J Surg Pathol (2009) 0.82
Cytokeratin expression in gastrointestinal stromal tumor: a clinicopathologic and immunohistochemical study of 687 cases. Appl Immunohistochem Mol Morphol (2012) 0.81
Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities. Ann Diagn Pathol (2006) 0.81
Metastasizing "benign" fibrous histiocytoma of the skin: a report of two additional cases and review of the literature. Adv Anat Pathol (2006) 0.81
Phyllodes tumor: Review of key imaging characteristics. Breast Dis (2015) 0.81
PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol (2014) 0.80
Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors. Anticancer Res (2010) 0.80
Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases. Pathol Int (2008) 0.80
Solitary fibrous tumor with atypical histological features occurring in the palatine tonsil: an uncommon neoplasm in an uncommon site. J Oral Pathol Med (2006) 0.80
Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma. Am J Dermatopathol (2012) 0.80